COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 724: Articles 7231-7240  | Next

A hospital-based study to assess various biomarkers for prognostic prediction of clinical outcome in COVID-19 disease.
Padhi, A., Shaw, D., Khatoon, S., Ranjan, S., Bhargava, A., Negi, S. S.
10.1101/2022.05.25.22275583 — Posted: 2022-05-27
Pilot study to evaluate hypercoagulation and inflammation using rotational thromboelastometry and calprotectin in COVID-19 patients.
Roy, A., Stanford, S., Rea, C., Harris, B., Ashton, A., Mangles, S., Everington, T., Taher, R., Burns, D., Arbuthnot, E., Cecil, T.
10.1101/2022.05.27.22275701 — Posted: 2022-05-27
Impact of the COVID-19 pandemic on Latino families with Alzheimer's disease and related dementias: Perceptions of family caregivers and primary care providers
Perales-Puchalt, J., Peltzer, J., Fracachan-Cabrera, M., Perez, A. G., Ramirez-Mantilla, M., Greiner, K. A., Burns, J. M.
10.1101/2022.05.25.22275517 — Posted: 2022-05-27
Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery
Milazzo, F. M., Chaves-Sanjuan, A., Minenkova, O., Santapaola, D., Anastasi, A. M., Battistuzzi, G., Chiapparino, C., Rosi, A., Merlo Pich, E., Albertoni, C., Marra, E., Luberto, L., Viollet, C., Spagnoli, L. G., Riccio, A., Rossi, A., Santoro, M. G., Ballabio, F., Paissoni, C., Camilloni, C., Bolognesi, M., De Santis, R.
10.1101/2022.05.27.493569 — Posted: 2022-05-27
Immunogenicity and Safety of Beta Adjuvanted Recombinant Booster Vaccine
LAUNAY, O., Cachanado, M., Luong Nguyen, L. B., Ninove, L., Lachatre, M., Ben Ghezala, I., Bardou, M., Schmidt -Mutter, C., Felten, R., Lacombe, K., Surgers, L., Laine, F., Allain, J.-S., Botelho-Nevers, E., Tavolacci, M.-P., Chidiac, c., Pavese, P., Dussol, B., Priet, S., Deplanque, D., Touati, A., Curci, L., Konate, E., Ben Hamouda, N., Besbes, A., Nubret, E., Capelle, F., Berard, L., Rousseau, A., Tartour, E., Simon, T., De Lamballerie|, X.
10.1101/2022.05.25.22274904 — Posted: 2022-05-27
Facing the Omicron variant - How well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
Kuelper-Schiek, W., Piechotta, V., Pilic, A., Batke, M., Dreveton, L.-S., Geurts, B., Koch, J., Koeppe, S., Treskova, M., Vygen-Bonnet, S., Waize, M., Wichmann, O., Harder, T.
10.1101/2022.05.25.22275516 — Posted: 2022-05-27
How is the COVID-19 pandemic impacting our life, mental health, and well-being? Design and preliminary findings of the pan-Canadian longitudinal COHESION Study
Gabet, S., Thierry, B., Wasfi, R., De Groh, M., Simonelli, G., Hudon, C., Lessard, L., Dube, E., Nasri, B., Kestens, Y., Moullec, G.
10.1101/2022.05.26.22275645 — Posted: 2022-05-27
A rapid One-Pot RNA-isolation method for simplified clinical detection of SARS-COV-2 infection in India
Jain, S., Bhowmick, A., Pandey, A. K.
10.1101/2022.05.26.22275661 — Posted: 2022-05-27
Epidemiological Interactions of Influenza and SARS-CoV-2 within a University Population During Omicron B.1.1.529 Outbreak
Malampy, R., Ganz, T., DeOliveira, G. M., Le, C. T., Li, K. M., Auclair, J.
10.1101/2022.05.26.22275641 — Posted: 2022-05-27
Molecular Investigations of Selected Spike Protein Mutations in SARS-CoV-2: Delta and Omicron Variants and Omicron BA.2 Sub Variant
Roy, U.
10.1101/2022.05.25.493484 — Posted: 2022-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).